REGENXBIO
3 followers
‌
REGENXBIO is seeking to improve lives through the curative potential of gene therapy. Our NAV® Technology Platform has ushered in a new era of gene therapy innovation.
Industries
Headquarters
Employees
Links
Org chart
Ken Mills
President & CEO
Ken Mills
Collapse
Curran M. Simpson
President And CEO
Steve Pakola
Chief Medical Officer
Olivier Danos
Chief Scientific Officer
Shiva G. Fritsch
Chief Communications & People Officer
Patrick J. Christmas II
Chief Legal Officer
Laura Coruzzi
EVP, Intellectual Property
Ram Palanki
EVP, Commercial Strategy & Operations
Gina McCabe
Manager, People & Finance Operations
Mark Murphy
Senior Vice President, Finance
Patrick O'Malley
Senior Director, Controller
